Blog

3D-Printed Medical Devices Market Analysis and Company Insights (2023 – 2032)

The 3D-printed medical devices market is expected to grow significantly, from USD 3.41 billion in 2022 to an estimated USD 17.76 billion by 2032, reflecting a compound annual growth rate (CAGR) of 17.94% from 2023 to 2032. This growth is driven by increasing demand for customized 3D-printed medical solutions.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5072

The Surge of Customization and Personalization in 3D-Printed Medical Devices

The 3D printing industry has revolutionized medical and industrial applications, moving beyond its origins in prototyping to become a viable choice for end-use products and large-scale manufacturing. Over the past few years, the technology has expanded beyond consumer markets and is now widely adopted in commercial production. Significant industry advancements have allowed 3D printing to evolve from a prototyping tool to a key player in manufacturing and end-use applications.

The COVID-19 pandemic highlighted the unique advantages of 3D printing in addressing production and supply chain challenges. With the ability to manufacture parts locally and on demand, 3D printing proved to be a valuable solution during times of crisis. During the pandemic, manufacturers used 3D printing to quickly produce critical medical devices and protective equipment (PPE), such as ventilator valve parts, face shields, and even nasal swabs for COVID-19 testing. This showcased the potential for mass production and helped the 3D-printed medical devices market boom.

Key Trends in the 3D-Printed Medical Devices Market

• Patient-Specific Solutions: The market is increasingly focused on creating personalized medical devices tailored to individual patients, improving treatment outcomes.
• Healthcare Expertise: The healthcare sector is leading the charge, with a strong understanding of regulatory requirements and technological applications.
• Long-Term Growth: A strong pipeline of innovations supports continued growth in the market.
• Market Expansion: There is growing interest in entering new markets and increasing the adoption of 3D printing in existing ones.
• Automation: The use of automation is on the rise in the 3D printing process, including the integration of collaborative robots (cobots) and post-processing techniques.

Collaboration Across the Value Chain

Given the critical nature of patient care, the 3D-printed medical device industry requires careful coordination among various players. The value chain for these devices is complex, with multiple stakeholders—each with distinct expertise—needing to work together. However, there is a lack of cooperation due to different 3D printing processes and systems, which complicates collaboration. Manufacturers must also pay closer attention to how upstream and downstream processes impact the final product, as emphasized in recent guidelines from the US FDA.

Lowering the Costs of Medical Devices

3D printing is helping reduce the high costs associated with medical device manufacturing, which often involves expensive and time-consuming traditional processes. By using digital designs to directly manufacture devices, 3D printing eliminates many labor-intensive steps and complex procedures that traditionally drive up production costs.

Over 90% of the largest medical device manufacturers now use 3D printing for prototyping and creating equipment and tools for testing. This has led to significant cost savings—one manufacturer reported saving up to 70% on production costs. Additionally, using 3D-printed models in 10-15% of cases could save up to $1.75 million annually.

3D printing is also making custom-fit prosthetics more affordable and accessible. Traditionally expensive, these prosthetics are now being designed using 3D printing to reduce costs and offer personalized solutions to patients, even in developing countries. Surgical instruments are also being manufactured more efficiently through 3D printing, with designs easily adapted for specific needs.

By enabling on-demand and localized production, 3D printing eliminates the need for extensive shipping and warehousing, further reducing costs. Custom medical devices, such as implants and surgical guides tailored to a patient’s unique anatomy, are improving outcomes and reducing the need for costly replacements, lengthy hospital stays, and complicated modifications.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/3d-printed-medical-devices-market

Access exclusive insight now @ https://www.towardshealthcare.com/price/5072

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Global Blood Pressure Monitoring Devices Market Growth, Trends and Key Players (2023 – 2032)

The global market for blood pressure monitoring devices was valued at USD 1.47 billion in 2022 and is projected to reach USD 3.35 billion by 2032. This represents a compound annual growth rate (CAGR) of 9.1% from 2023 to 2032.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5001

Hypertension Awareness and the Demand for Blood Pressure Monitoring Devices

According to the World Health Organization (WHO), around 1.28 billion adults between the ages of 30 and 79 are affected by hypertension. However, only 42% of these individuals are properly diagnosed and treated, leaving the majority unaware of their condition. Most of these undiagnosed cases are found in low to middle-income countries. Despite this, growing awareness about the health risks associated with hypertension is expected to drive increased demand for blood pressure monitoring devices.

Impact of COVID-19 on the Blood Pressure Monitoring Devices Market

In 2019, blood pressure monitors were in high demand in regions like China, Europe, and Asia. However, demand in North America fell due to trade tensions between the US and China, and Japan saw a decline due to a consumption tax hike and other factors. The global market was also affected in the fourth quarter by the onset of COVID-19.

In 2020, the pandemic increased the global demand for blood pressure monitors and thermometers as health management became even more crucial. With restrictions on non-essential movement, online sales channels saw significant growth.

COVID-19 also accelerated the adoption of telemedicine worldwide, as patients with chronic conditions like hypertension, diabetes, and others had to avoid hospital visits to reduce the risk of exposure. As a result, these patients needed alternative ways to manage their health remotely.

To address this, OMRON has developed a remote patient monitoring service that allows patients to measure their vital signs at home using devices like blood pressure monitors, ECG monitors, and body composition scales. The data is then shared with doctors and nurses, allowing patients to receive advice and care without leaving their homes or visiting a hospital. This innovative approach to telemedicine is helping to meet the needs of patients in the “new normal” created by the pandemic.

Remote Patient Monitoring (RPM) and Hypertension Care

In August 2020, OMRON introduced its VitalSight™ remote patient monitoring system at Mount Sinai Hospital in New York, one of North America’s top medical institutions. Through this system, patients with high blood pressure can use the “OMRON connect” health management app or a specialized communications hub to send their daily blood pressure readings and body composition data directly to the hospital’s electronic medical records (EMR). This allows doctors and nurses to communicate easily about the patient’s condition.

This RPM approach enables healthcare providers to monitor patients’ daily health and adjust treatment plans more effectively. It also allows patients to stay in regular contact with their doctors, which encourages them to take an active role in managing their health and improves treatment adherence. As part of its strategy to expand its data services, OMRON is working to offer more RPM-based hypertension treatment options in North America, where nearly half of the population has high blood pressure.

Online Hypertension Consultation Service in Japan

In Japan, online consultations are seen as a complement to in-person visits. Currently, only about 12 million of the 43 million people with high blood pressure are effectively managing their condition, while around 29% are on medication but not getting their blood pressure properly controlled. Another 11% (4.5 million) are aware of their hypertension but not seeking treatment, and 33% (14 million) don’t even know they have it.

One major barrier to treatment is that hospital visits can be difficult for elderly patients, while busy individuals often lack the time for clinic appointments. To address these issues, OMRON launched “telemedEASE BPTM” in May 2019, an online hypertension consultation service developed in partnership with the telemedEASE association. This service allows patients to manage their hypertension from home or work, including monitoring their blood pressure, making appointments, receiving diagnoses and prescriptions, getting medication, and even paying bills. The COVID-19 pandemic has further accelerated the acceptance of telemedicine in Japan, with hopes for regulatory changes to support its continued growth.

Growing Senior Population and Blood Pressure Concerns

As life expectancy increases and fertility rates decline, the global population is aging. By 2020, there were 727 million people aged 65 or older. In the next 30 years, this number is expected to more than double, reaching 1.5 billion by 2050. As a result, the percentage of the global population aged 65 and over will rise from 9.3% in 2020 to about 16% by 2050.

While it was once believed that high blood pressure was simply a natural part of aging, we now know that the causes of blood pressure changes with age are more complex. Aging increases the likelihood that environmental or lifestyle factors will contribute to high blood pressure, but it is not inevitable.

Access exclusive insight now @ https://www.towardshealthcare.com/price/5001

port you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

Growth and Trends in the U.S. Behavioral Health Market (2023 – 2032)

In 2022, the U.S. behavioral health market was valued at $83.47 billion. The market is forecasted to grow at a compound annual growth rate (CAGR) of 5.1%, reaching an estimated $136.60 billion by 2032.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5007

The Impact of COVID-19 on the U.S. Behavioral Health Market

Behavioral health conditions, including drug abuse and mental illnesses, were significantly affected by the COVID-19 pandemic in 2020 and 2021. The pandemic’s widespread disruption intensified mental health challenges, increasing both physical and mental health issues across the country.

Mental Health Challenges During the Pandemic

The COVID-19 pandemic and the resulting economic downturn negatively impacted the mental well-being of many Americans. For individuals already struggling with mental health or addiction, the pandemic introduced even greater hurdles. Reports indicate that 4 in 10 U.S. adults experienced symptoms of anxiety or depression during the pandemic, a sharp increase from the 1 in 10 reported before the crisis, between January and June 2019.

A Kaiser Family Foundation (KFF) survey conducted in July 2020 highlighted specific effects of the pandemic on mental health. These included difficulty sleeping (36%) and eating (32%) due to stress, increased use of alcohol or substances (12%), and worsening of chronic health conditions (12%). Public health measures, such as lockdowns and isolation, further exacerbated these mental health struggles.

Substance Use and Mental Health Disorders

Concerns around mental health and substance use escalated during the pandemic. By early 2021, 41% of people reported symptoms of anxiety or depression, a trend consistent since early 2020. A June 2020 survey revealed that 13% of respondents had increased their substance use due to pandemic-related stress, while 11% reported contemplating suicide in the prior 30 days. The pandemic also contributed to a surge in drug overdose deaths, which rose significantly between March and May 2020 as lockdowns began.

Social isolation, a key factor during the pandemic, has long been linked to poor mental and physical health. Research shows that loneliness increases the risk of chronic conditions and can even shorten life expectancy. A March 2020 KFF poll found that individuals who followed stay-at-home orders were more likely to report negative mental health effects due to pandemic-related stress or fear.

Long-Term Behavioral Health Outlook

The effects of the pandemic on mental health and substance use are likely to persist long after the immediate crisis. Historical data indicates that the psychological impacts of disasters often outlast their physical consequences. For example, healthcare workers have reported distress for up to three years following previous outbreaks. The economic downturn linked to the pandemic is also expected to contribute to “deaths of despair” from suicide and substance abuse through at least 2027.

To address this prolonged demand, policymakers must consider strategies to expand access to mental health and addiction services, even as COVID-19 cases decline.

The Role of Telehealth

The pandemic accelerated the adoption of telehealth for behavioral health services. Virtual care has emerged as a key solution, providing broader access to therapy and addiction treatment. Telehealth programs, such as the Eastern Shore Mobile Care Collaborative in Maryland, have improved care for opioid use disorder in rural areas.

Rise of Digital Behavioral Health

The crisis also drove innovation and investment in digital behavioral health. Searches for “virtual mental health” surged after early 2020, and studies found that about one in five COVID-19 patients received a diagnosis of conditions like anxiety, depression, or insomnia within three months of infection.

This shift toward digital care attracted significant funding, with behavioral health companies raising nearly $1.6 billion in 2020. This marked a 47% increase in investment by the end of 2020 compared to the previous year, highlighting the sector’s rapid growth despite pandemic-related challenges.

Access exclusive insight now @ https://www.towardshealthcare.com/price/5007

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare